Provided by Tiger Fintech (Singapore) Pte. Ltd.

REMEGEN

86.150
+1.6501.95%
Volume:1.73M
Turnover:146.91M
Market Cap:48.55B
PE:-28.82
High:87.000
Open:83.200
Low:82.700
Close:84.500
52wk High:126.600
52wk Low:11.520
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:0.97
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.989
ROE:-40.42%
ROA:-9.72%
PB:19.11
PE(LYR):-28.82
PS:19.90

Loading ...

Caitong Securities: Phosphoramidite Monomer Demand to Boom, Companies in MNC Pharma Supply Chains Set to Benefit

Stock News
·
Oct 29

HK Stock Connect Shareholding Changes | Oct 28

Stock News
·
Oct 28

RemeGen (SEHK:9995) Is Down 8.4% After Breakthrough Phase III Results Gain Global Recognition – Has the Bull Case Changed?

Simply Wall St.
·
Oct 26

Asian Growth Companies With High Insider Ownership In October 2025

Simply Wall St.
·
Oct 22

RemeGen (9995) Schedules Board Meeting on October 30, 2025 to Review Unaudited Third Quarterly Results

Bulletin Express
·
Oct 17

Hong Kong Stock Market Analysis | Various Manipulations Behind Many Strategies and Severe Volume Reduction Favours Consumer Giants

Stock News
·
Oct 16

Stock Track | REMEGEN Soars 6.36% as Lupus Treatment Study Published in Prestigious Medical Journal

Stock Track
·
Oct 16

Hong Kong Stocks Update: REMEGEN (09995) Rises Over 5% After NEJM Publication of Lupus Treatment Study

Stock News
·
Oct 16

RemeGen (SEHK:9995): Assessing Valuation After 25% Revenue Growth and a 2% Share Price Gain

Simply Wall St.
·
Oct 16

REMEGEN (09995) Purchases 500 Million Yuan Financial Products

Stock News
·
Oct 15

Stock Track | REMEGEN Soars 5.31% as Telitacicept Gains Regulatory Traction and New Leadership Appointment

Stock Track
·
Oct 15

Hong Kong Stock Movement | REMEGEN (09995) Surges Nearly 5% in Early Trading as Telitacicept's IgA Nephropathy Treatment Application Receives Acceptance and Priority Review

Stock News
·
Oct 15

Biotech Stocks Jump. Immunotech up 17%; Carsgen up 14%; BRII up 6%; JW Therap up 4%; Sirnaomics up 3%

Tiger Newspress
·
Oct 06

Selling CN¥67m Of RemeGen Stock Rewarded Insiders

Simply Wall St.
·
Oct 06

Stock Track | REMEGEN Soars 7.41% as Ophthalmology Drug Files for Approval and ESMO Presentations Announced

Stock Track
·
Sep 30

REMEGEN Surges Over 7% Intraday as Ophthalmology Drug Iledefusp α (RC28) Files for Market Approval

Deep News
·
Sep 30

Hong Kong Pharmaceuticals Rise as Trump Drug Tariffs Show Limited Impact; Q4 BD Events Expected

Stock News
·
Sep 29

BOCOM International: Trump's Drug Tariffs Have Limited Impact on Chinese Pharmaceuticals, Recommends Focus on AKESO (09926) and Others

Stock News
·
Sep 29

Stock Track | REMEGEN Soars 7.75% as Key Drug Enters Priority Review for IgA Nephropathy Treatment

Stock Track
·
Sep 29

Stock Track | REMEGEN Soars 7.75% as Telitacicept Enters Priority Review for IgA Nephropathy Treatment

Stock Track
·
Sep 29